Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK11 | Q15759 | 16/20 | 0.75 |
| ▸ | MAPK14 | Q16539 | 16/20 | 0.75 |
| ▸ | MAPK13 | O15264 | 15/20 | 0.75 |
| ▸ | MAPK12 | P53778 | 15/20 | 0.75 |
| ▸ | GCGR | P47871 | 14/20 | 0.75 |
| ▸ | CSNK1A1 | P48729 | 5/20 | 0.75 |
| ▸ | CSNK1D | P48730 | 5/20 | 0.75 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.75 |
| ▸ | MAP4K4 | O95819 | 4/20 | 0.75 |
| ▸ | FRK | P42685 | 4/20 | 0.75 |
| ▸ | MAPK9 | P45984 | 4/20 | 0.75 |
| ▸ | GSK3B | P49841 | 4/20 | 0.75 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.75 |
| ▸ | PTK6 | Q13882 | 3/20 | 0.75 |
| ▸ | PRKD2 | Q9BZL6 | 3/20 | 0.75 |
| ▸ | ALOX5 | P09917 | 13/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | CSNK1E | P49674 | 3/20 | 0.67 |
| ▸ | CSNK1A1L | Q8N752 | 3/20 | 0.67 |
| ▸ | PRKACA | P17612 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9192799 | 1.00 | MAPK11 (0.75) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| Sb-203580 SCHEMBL27075368 | 1.00 | MAPK11 (0.75) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| Sb-203580 SCHEMBL220990 | 1.00 | MAPK11 (0.75) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| Sb-203580 SCHEMBL25800837 | 1.00 | MAPK11 (0.75) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| Sb-203580 SCHEMBL146399 | 1.00 | MAPK11 (0.75) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| Sb-203580 SCHEMBL4890447 | 0.99 | MAPK11 (0.73) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| SCHEMBL20335254 | 0.90 | MAPK11 (0.79) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| SCHEMBL6447875 | 0.89 | MAPK13 (0.72) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| SCHEMBL1389121 | 0.87 | MAPK14 (0.67) | MAPK11MAPK14MAPK13MAPK12GCGR | |
| SCHEMBL6606221 | 0.87 | MAPK11 (0.70) | MAPK11MAPK14MAPK13MAPK12GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2797 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132384-A1 | METHOD FOR REPROGRAMMING HUMAN SOMATIC CELLS INTO INDUCED PLURIPOTENT STEM CELLS | EXONEUGLIA BIOTECHNOLOGY (SUZHOU) CO., LTD. (CN) | 2026-05-14 | — | — | US | claimed |
| EP-4741496-A1 | METHOD FOR REPROGRAMMING HUMAN SOMATIC CELLS INTO INDUCED PLURIPOTENT STEM CELLS | Exoneuglia Biotechnology (Suzhou) Co., Ltd. (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20260109951-A1 | METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION | FATE THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| EP-4720261-A1 | NOVEL CULTURE CONDITIONS FOR CLONAL EXPANSION OF NEPHRON PROGENITOR CELLS, GENERATION OF NEPHRON ORGANOIDS, AND RAPID AND SCALABLE MODELING OF POLYCYSTIC KIDNEY DISEASE | University of Southern California (US) | 2026-04-08 | — | — | EP | claimed |
| US-20260022341-A1 | METHOD OF GENERATING A HOMOCELLULAR PROGENITOR CELL CULTURE FROM A HETEROCELLULAR TISSUE SAMPLE | Mosa Meat B.V. (NL) | 2026-01-22 | — | — | US | claimed |
| US-20260015632-A1 | CULTURE MEDIUM COMBINATION FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CD34+ HEMATOPOIETIC STEM/PROGENITOR CELLS | SHENZHEN CELL INSPIRE BIOTECHNOLOGY CO., LTD. (CN) | 2026-01-15 | — | — | US | claimed |
| EP-4665845-A1 | PLURIPOTENT STEM CELL-ENGINEERED IMMUNE CELLS FOR OFF-THE-SHELF CELL THERAPY | The Regents of University of California (US) | 2025-12-24 | — | — | EP | claimed |
| US-12503685-B2 | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2025-12-23 | — | — | US | claimed |
| US-20250340848-A1 | METHODS FOR CHEMICAL REPROGRAMMING AND PLURIPOTENT STEM CELLS | PEKING UNIVERSITY (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4640238-A1 | THERAPEUTIC AGENT FOR PULMONARY DISEASE, HEPATIC DISEASE OR RENAL DISEASE, WHICH CONTAINS PGAM-CHK1 BINDING INHIBITOR | Kyoto University (JP) | 2025-10-29 | — | — | EP | claimed |
| US-20020028798-A1 | Irrigation solution and method for inhibition of pain and inflammation | OMEROS MEDICAL SYSTEMS | 2002-03-07 | — | — | US | claimed |
| US-6288089-B1 | ADMINISTERING A COMPOSITION OF PYRIDYL IMIDAZOLE COMPOUNDS TO TREAT PARKINSON'S DISEASE, HUNTINGTON'S DISEASE, ALZHEIMER'S DISEASE, AND AMYOTOPHIC LATERAL SCLEROSIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-09-11 | — | — | US | claimed |
| US-6235760-B1 | CENTRAL NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS | SMITHKLINE BEECHAM CORPORATION | 2001-05-22 | — | — | US | claimed |
| WO-2001019322-A2 | USE OF CSAIDS IN RHINOVIRUS INFECTION | SMITHKLINE BEECHAM CORPORATION (US) | 2001-03-22 | — | — | WO | claimed |
| WO-2000023072-A1 | IRRIGATION SOLUTION CONTAINING MAPK INHIBITORS AND THEIR USE FOR TREATING PAIN AND INFLAMMATION | OMEROS MEDICAL SYSTEMS, INC. (US) | 2000-04-27 | — | — | WO | claimed |
| EP-0889887-A1 | NOVEL TREATMENT FOR CNS INJURIES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-01-13 | — | — | EP | claimed |
| WO-1997035855-A1 | NOVEL TREATMENT FOR CNS INJURIES | SMITHKLINE BEECHAM CORPORATION (US) | 1997-10-02 | — | — | WO | claimed |
| US-5656644-A | CYTOKINE SUPPRESSORS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-08-12 | — | — | US | claimed |
| EP-0623126-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-09 | — | — | EP | claimed |
| WO-1993014081-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-07-22 | — | — | WO | claimed |